What is Wave Life Sciences's change in AP?

Wave Life Sciences (WVE) reported change in AP of $3.29M in Q1 2026.

How has Wave Life Sciences's change in AP changed year-over-year?

Wave Life Sciences's change in AP increased by 260.3% year-over-year, from -$2.05M to $3.29M.

What is the long-term trend for Wave Life Sciences's change in AP?

Over 2 years (2021 to 2024), Wave Life Sciences's change in AP has grown at a -27.8% compound annual growth rate (CAGR), from -$6.57M to $3.42M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Wave Life Sciences WVE Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

Sarepta Therapeutics, Inc.SRPT

-$210.47M-261%

Ionis PharmaceuticalsIONS

-$3.1M+88.1%

Madrigal Pharmaceuticals, Inc.MDGL

$3.58M+332%

ALN

Alnylam PharmaceuticalsALNY

-$176.03M-11.6%

Beam TherapeuticsBEAM

$2.22M-41.6%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's change in AP?: Wave Life Sciences (WVE) reported change in AP of $3.29M in Q1 2026.
How has Wave Life Sciences's change in AP changed year-over-year?: Wave Life Sciences's change in AP increased by 260.3% year-over-year, from -$2.05M to $3.29M.
What is the long-term trend for Wave Life Sciences's change in AP?: Over 2 years (2021 to 2024), Wave Life Sciences's change in AP has grown at a -27.8% compound annual growth rate (CAGR), from -$6.57M to $3.42M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.